TheraCryf PLC

LSE:TCF (UK)  
£ 0.01 (0%) Apr 26
At Loss
P/B:
0.57
Market Cap:
£ 3.42M ($ 4.29M)
Enterprise V:
£ -309.00K ($ -387.00K)
Volume:
227.41K
Avg Vol (2M):
1.19M
Also Trade In:
Volume:
227.41K
At Loss
Avg Vol (2M):
1.19M

Business Description

Description
TheraCryf PLC is a clinical stage therapeutics company developing a new generation of innovative therapeutics in oncology and behavioural brain disorders.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.91
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -4.96
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 69.22
9-Day RSI 43.36
14-Day RSI 36.39
6-1 Month Momentum % -55.13
12-1 Month Momentum % -76.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.39
Quick Ratio 10.39
Cash Ratio 8.98
Days Sales Outstanding 166.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -26.9